首页 > 市场调查报告书 > 製药

基因治疗学和RNAi

市场调查报告书

商品编码

1532426

RNAi 技术市场：按应用、按最终用户、按地区

Rnai Technology Market, By Application, By End User, By Geography

出版日期: 2024年07月01日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

全球RNAi技术市场预计到2024年将达到27亿美元，预计2031年将达到71亿美元，2024年至2031年的复合年增长率为14.8%。

报告范围		报告详情
基准年	2023年	2024年市场规模	27亿美元
实际资料	2019-2023	预测期	2024年至2031年
预测 2024-2031 年复合年增长率：	14.80%	2031年价值预测	71亿美元

图：2024 年按地区分類的 RNAi 技术市场占有率(%)

全球RNAi技术市场的成长是由RNA干扰技术在治疗药物开发和研究中不断扩大的应用所推动的。 RNA干扰或RNAi是指由短干扰RNA（siRNA）或微型RNA（miRNA）介导的基因静默过程。 RNAi 已成为选择性抑制基因表现和功能基因组学筛选的强大工具。 RNAi 具有透过定序特定致病基因来开发新型治疗药物的巨大潜力。安全有效的递送系统的发展将进一步促进基于RNAi的治疗方法的商业化。生物製药公司和政府组织对 RNAi 研发的大量投资催生了强大的产品平臺。

市场动态：

推动全球RNAi技术市场成长的是RNAi技术在跨学科治疗开发中的广泛应用。目前，多种候选药物正在进行针对代谢、心血管和神经退化性疾病的临床试验。强大的产品平臺和新型 RNAi 药物的进入使人们对该技术的治疗潜力更加乐观。然而，RNAi 递送中的技术挑战和脱靶效应可能会阻碍市场成长。此外，建设研发基础设施和临床开发所需的大量资本投资也阻碍了许多小型企业的发展。继续研究透过脂质奈米粒子、聚合物奈米粒子和配体结合分子等新型递送系统克服递送挑战可能会提供市场成长机会。基于 RNAi 的药物在后期临床试验中取得的有前景的临床结果可能会为市场成长提供机会。

本研究的主要特点

本报告对全球RNAi技术市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球 RNAi 技术市场的主要企业。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球RNAi技术市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
透过用于分析全球 RNAi 技术市场的各种策略矩阵，将有助于相关人员做出决策。

公司简介
- Alnylam Pharmaceuticals
- OriGene Technologies, Inc.
- Arrowhead Pharmaceuticals
- Dicerna Pharmaceuticals
- Silence Therapeutics
- Ionis Pharmaceuticals
- Merck &Co.
- Qiagen NV
- Thermo Fisher Scientific
- Synlogic
- Benitec Biopharma
- Gradalis
- Sirnaomics, Inc.
- Marina Biotech
- Quark Pharmaceuticals
- Regulus Therapeutics
- GeneCare Research Institute Co., Ltd.
- ASC Therapeutics

第九章分析师建议

命运之轮
分析师观点
一致的机会图

第10章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI5281

Global RNAi technology market is estimated to be valued at USD 2.70 Bn in 2024 and is expected to reach USD 7.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.8% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 2.70 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	14.80%	2031 Value Projection:	US$ 7.10 Bn

Figure. RNAi technology market Share (%), By Region 2024

Global RNAi technology market growth is driven by growing applications of RNA interference technology in therapeutics development and research. RNA interference or RNAi refers to the process of gene silencing mediated by short interfering RNAs (siRNAs) or microRNAs (miRNAs). It has emerged as a powerful tool for selective inhibition of gene expression and functional genomics screens. RNAi holds immense potential for developing novel therapeutics by silencing specific disease-causing genes. The development of safe and effective delivery systems further contributes to the commercialization of RNAi-based therapies. Significant investments in RNAi research and development from biopharma companies and government organizations are resulting in a strong product pipeline.

Market Dynamics:

Global RNAi technology market growth is driven by increasing applications of RNAi technology for developing treatments across therapeutic areas. Several drug candidates targeting metabolic, cardiovascular and neurodegenerative disorders are currently under clinical trials. The strong product pipeline and entry of novel RNAi drugs are creating high optimism around the therapeutic potential of this technology. However, technical challenges in RNAi delivery and off-target effects can hamper the market growth. Moreover, requirement of high capital investments for building R&D infrastructure and clinical development deters many small companies. Ongoing research on overcoming the delivery challenges through novel delivery systems such as lipid nanoparticles, polymeric nanoparticles and ligand-conjugated molecules can offer market growth opportunities. Promising clinical outcomes of RNAi-based drugs in late-stage trials can offer market growth opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global RNAi technology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global RNAi technology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Mirna Therapeutics, and Quark Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global RNAi technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global RNAi technology market

Detailed Segmentation-

By Application
- Drug Discovery and Development
- Therapeutics
- Neurology
- Oncology
- Infectious Diseases
- Metabolic Diseases
- Others
- Functional Genomics
- Other
By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- CROs & CMOs
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Alnylam Pharmaceuticals
- OriGene Technologies, Inc.
- Arrowhead Pharmaceuticals
- Dicerna Pharmaceuticals
- Silence Therapeutics
- Ionis Pharmaceuticals
- Merck & Co.
- Qiagen N.V.
- Thermo Fisher Scientific
- Synlogic
- Benitec Biopharma
- Gradalis
- Sirnaomics, Inc.
- Marina Biotech
- Quark Pharmaceuticals
- Regulus Therapeutics
- GeneCare Research Institute Co., Ltd.
- ASC Therapeutics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Rnai Technology Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global RNAi Technology Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Drug Discovery and Development
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Therapeutics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurology
Oncology
Infectious Diseases
Metabolic Diseases
Others
Functional Genomics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global RNAi Technology Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Pharmaceutical & Biotechnology Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
CROs & CMOs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global RNAi Technology Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Alnylam Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- OriGene Technologies, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Arrowhead Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Dicerna Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Silence Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ionis Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Qiagen N.V.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Thermo Fisher Scientific
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Synlogic
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Benitec Biopharma
- Gradalis
- Sirnaomics, Inc.
- Marina Biotech
- Quark Pharmaceuticals
- Regulus Therapeutics
- GeneCare Research Institute Co., Ltd.
- ASC Therapeutics

9. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

RNAi 技术市场：按应用、按最终用户、按地区